NCT01377597View on ClinicalTrials.gov

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Retinal Vein Occlusion
Interventions
DRUG

ranibizumab

Trial Locations (8)

466-8560

Novartis Investigative Site, Nagoya

467-8602

Novartis Investigative Site, Nagoya

812-8582

Novartis Investigative Site, Fukuoka

761-0793

Novartis Investigative Site, Kita-gun

606-8507

Novartis Investigative Site, Kyoto

545-8586

Novartis Investigative Site, Osaka

565-0871

Novartis Investigative Site, Suita

520-2192

Novartis Investigative Site, Ohtsu

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY